Gerhard Fries

Title: Gerhard Fries: Innovator in Pharmaceutical Preparations

Introduction

Gerhard Fries is a notable inventor based in Magdeburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the bioavailability of active ingredients in drug formulations. His innovative approach has the potential to improve the effectiveness of oral medications.

Latest Patents

Fries holds a patent for a composition and methods aimed at providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (HMLO). This patent focuses on improving the absorption of HMLO by incorporating bile acids into the pharmaceutical preparation. The use of bile acids, such as desoxycholic acid or dehydrocholic acid, significantly enhances the drug's effectiveness when administered orally.

Career Highlights

Gerhard Fries has worked with Veb Fahlberg-List Chemische Und Pharmazeutische Fabriken, where he has applied his expertise in pharmaceutical sciences. His work has been instrumental in developing formulations that maximize the therapeutic potential of various active ingredients.

Collaborations

Fries has collaborated with notable colleagues, including Jurgen Slapke and Reinhard Neubert. These partnerships have contributed to the advancement of pharmaceutical innovations and the successful development of new drug formulations.

Conclusion

Gerhard Fries is a distinguished inventor whose work in enhancing drug bioavailability has made a significant impact in the pharmaceutical industry. His innovative methods and collaborations continue to pave the way for advancements in medication effectiveness.